Pages that link to "Q41392171"
Jump to navigation
Jump to search
The following pages link to Effects of ritanserin on sleep disturbances of dysthymic patients (Q41392171):
Displaying 26 items.
- Drugs versus placebo for dysthymia (Q24187378) (← links)
- Drugs versus placebo for dysthymia (Q24246945) (← links)
- Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs (Q28302616) (← links)
- A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence (Q31799450) (← links)
- The search for determinants of chronic depression: a review of six factors (Q34138741) (← links)
- A dose-response study examining the effects of ritanserin on human slow wave sleep (Q34358184) (← links)
- Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist (Q34427738) (← links)
- Drug-Related Sleep Stage Changes: Functional Significance and Clinical Relevance (Q34587354) (← links)
- Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers (Q35108041) (← links)
- REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers (Q35180794) (← links)
- Serotonin and sleep-wakefulness (Q38004452) (← links)
- Role of 5-HT2A receptor antagonists in the treatment of insomnia. (Q38101551) (← links)
- Synthesis, Structure Activity Relationship Studies and Pharmacological Evaluation of 2-Phenyl-3-(Substituted Phenyl)-3H-Quinazolin-4-ones as Serotonin 5-HT(2) Antagonists (Q40431275) (← links)
- Circadian rhythms and the pharmacology of affective illness (Q41240193) (← links)
- Combined administration of an mGlu2/3 receptor agonist and a 5-HT 2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants (Q43286008) (← links)
- Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers (Q43919885) (← links)
- Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol (Q43942856) (← links)
- 5-HT2 receptor antagonism and slow-wave sleep in major depression (Q44085915) (← links)
- The relationship between subjective sleep estimation and objective sleep variables in depressed patients (Q48719677) (← links)
- An open clinical and biochemical study of ritanserin in acute patients with schizophrenia (Q48852672) (← links)
- Effects of ritanserin and chlordiazepoxide on sleep-wakefulness alterations in rats following chronic cocaine treatment (Q48892173) (← links)
- Absence of withdrawal effects of ritanserin following chronic dosing in healthy volunteers (Q48892969) (← links)
- Failure of ritanserin to block cocaine cue reactivity in humans (Q51559252) (← links)
- Mianserin, a 5-HT2 receptor antagonist, in the treatment of delirium: an open study. (Q54015562) (← links)
- 5-HT2 receptors are partially involved in the relationship between renin release and delta relative power (Q59362554) (← links)
- Behavioural Profile of Two Potential Antidepressant Pyridazine Derivatives Including Arylpiperazinyl Moieties in Their Structure, in Mice (Q71849156) (← links)